Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

July 19, 2011

Primary Completion Date

September 19, 2013

Study Completion Date

September 19, 2013

Conditions
Essential Thrombocythemia (ET)
Interventions
DRUG

Anagrelide hydrochloride

0.5 mg hard capsules, dosing decisions will be made by the treating physician

Trial Locations (10)

20125

Fondazione IRCCS Ca' Granda, Milan

80131

"Azienda Ospedaliera Universitaria Federico II", Napoli

Unknown

Azienda Ospedaliera Policlinico di Bari, Bari

Istituto Seragnoli-Policlinico S.Orsola-Malpighi, Bologna

A.O. Spedali Civili di Brescia, Brescia

Azienda Ospedaliero-Universitaria Careggi, Florence

Ospedale San Martino, Genova

Ospedale Maggiore della Carita, Novara

Policlinico A. Gemelli, Roma

Padiglione ex-oncologico Ospedale S.Maria, Terni

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY